ASC Biosciences, Inc. (“ASC”) is a Biotechnology Company that has a disruptive technology in the field of regenerative medicine. ASC has solved the dosage challenge that has hampered the stem cell industry to date. ASC’s exclusive patented proprietary adult stem cell platform is capable of forming and improving nearly every tissue in the human body. The platform is comprised of Multipotent Adult Stem Cells (“MASCs”) which have an unlimited proliferation potential that facilitates the manufacture of trillions of cells. This inherent characteristic provides the ability to create significantly larger doses of cells needed to effect tissue regeneration. Dosage has been the major hurdle for the industry and ASC provides the solution.
Our experienced team of researchers have been published in dozens of scientific journals. Learn more about our recent contributions to the scientific community.
We are continuously developing new technology of significant clinical values. Learn more about our competitive advantage in tisse engineering.
Learn More about our unique “regenerative” products compromised of Proprietary MASCsTM.